Multicenter Reproducibility of <sup>18</sup>F-Fluciclatide PET Imaging in Subjects with Solid Tumors
Rohini Sharma(Hammersmith Hospital), Eric O. Aboagye(Imperial College London), Edward J. Somer(General Electric (Spain)), Norbert Avril(University Hospitals of Cleveland), R. Charles Coombes(Imperial College London), Henrik Lindman(Uppsala University), Fergus Gleeson(Churchill Hospital), Ramanathapuram Parameswaran(Manipal Hospital), Matthew P. Miller, Ashley M. Groves(University College London), Jin Sook Ryu(Asan Medical Center), Kyung-Han Lee(Samsung Medical Center), Kumar Kallur, Michael O’Doherty(King's College London), Jong D. Lee(Yonsei University Health System)
Cited by 23
Related Papers
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
|New England Journal of Medicine|2004|1.8k
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
|The Lancet|2007|912
Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
|PLoS ONE|2009|504
Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer
|European Journal of Cancer|2015|386